Scinai Immunotherapeutics Ltd. SCNI
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$0.52$0.57
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.65M | 1.66M | 1.66M | 1.66M | 989.00K |
| Total Receivables | 74.00K | 168.00K | 168.00K | 168.00K | 139.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 561.00K | 75.00K | 75.00K | 75.00K | 236.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 199.00K | 150.00K | 150.00K | 150.00K | 142.00K |
| Total Current Assets | 3.49M | 2.05M | 2.05M | 2.05M | 1.51M |
|
|
|||||
| Total Current Assets | 3.49M | 2.05M | 2.05M | 2.05M | 1.51M |
| Net Property, Plant & Equipment | 13.69M | 9.57M | 9.57M | 9.57M | 10.33M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 17.18M | 11.63M | 11.63M | 11.63M | 11.84M |
|
|
|||||
| Total Accounts Payable | 844.00K | 407.00K | 407.00K | 407.00K | 659.00K |
| Total Accrued Expenses | -- | 759.00K | 759.00K | 759.00K | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 369.00K | 329.00K | 329.00K | 329.00K | 497.00K |
| Total Finance Division Other Current Liabilities | 1.02M | 90.00K | 90.00K | 90.00K | 964.00K |
| Total Other Current Liabilities | 1.02M | 90.00K | 90.00K | 90.00K | 964.00K |
| Total Current Liabilities | 2.23M | 1.59M | 1.59M | 1.59M | 2.12M |
|
|
|||||
| Total Current Liabilities | 2.23M | 1.59M | 1.59M | 1.59M | 2.12M |
| Long-Term Debt | 285.00K | 294.00K | 294.00K | 294.00K | 293.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.93M | 1.64M | 1.64M | 1.64M | 1.57M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 3.00K |
| Total Liabilities | 5.44M | 3.52M | 3.52M | 3.52M | 3.98M |
|
|
|||||
| Common Stock & APIC | 132.52M | 130.06M | 130.06M | 130.06M | 125.64M |
| Retained Earnings | -124.27M | -125.85M | -125.85M | -125.85M | -121.67M |
| Treasury Stock & Other | -2.14M | -1.74M | -1.74M | -1.74M | -1.74M |
| Total Common Equity | 6.11M | 2.48M | 2.48M | 2.48M | 2.23M |
|
|
|||||
| Preferred Stock Redeemable | 5.63M | 5.63M | 5.63M | 5.63M | 5.63M |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 5.63M | 5.63M | 5.63M | 5.63M | 5.63M |
|
|
|||||
| Total Common Equity | 6.11M | 2.48M | 2.48M | 2.48M | 2.23M |
| Total Preferred Equity | 5.63M | 5.63M | 5.63M | 5.63M | 5.63M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.73M | 8.10M | 8.10M | 8.10M | 7.86M |
|
|
|||||